Abstract
Various guidelines and risk indices have optimized cardiac risk stratification, and the emphasis has shifted to reducing perioperative risk. This review is an update on invasive (CABG/PCI) and noninvasive (medical therapy with beta-blockers, alpha-agonists, and statins) strategies to reduce cardiac risk for noncardiac surgery and the controversies surrounding their use.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 174-180 |
| Number of pages | 7 |
| Journal | Journal of Hospital Medicine |
| Volume | 2 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 1 2007 |
Keywords
- Beta-adrenergic blockers
- Coronary artery bypass
- Percutaneous coronary intervention
- Perioperative
- Preoperative care
- Risk assessment
- Statin
ASJC Scopus subject areas
- Health Policy
- Assessment and Diagnosis
- Care Planning
- Fundamentals and skills
- Leadership and Management
Fingerprint Dive into the research topics of 'Preoperative cardiac risk stratification 2007: Evolving evidence, evolving strategies'. Together they form a unique fingerprint.
Cite this
Cohn, S. L., & Auerbach, A. D. (2007). Preoperative cardiac risk stratification 2007: Evolving evidence, evolving strategies. Journal of Hospital Medicine, 2(3), 174-180. https://doi.org/10.1002/jhm.158